While the outbreak of COVID-19 is significantly impacting the healthcare industry in China amid all the uncertainties caused by the epidemic spread, the opportunities also lurk.
The European Union Chamber of Commerce in China jointly with Amcham Shanghai welcomes Jens Ewert, Partner at Deloitte to share the findings from their survey in response to the COVID-19 outbreak among 104 leading pharma companies in China. Key predictions for the healthcare sector in 2020 will be provided.
Executives from the healthcare industry will join the panel afterward to discuss how their companies are coping during this time of turbulent change and the opportunities they are observing now.
Agenda
10:30 am Welcome
10:35 am Opening remarks by Ker Gibbs, AmCham Shanghai President
10:45 am Presentation by Jens Ewert, Partner, Deloitte, European Chamber Shanghai Board Member and National Chair of the
Investment Working Group
11:05 am Panel discussion and Q&A
Panellists:
- Thomas Shao, Director of Government Affairs and Public Policy at Abbott China
- Jens Ewert, Parter, Deloitte China
- Valtero Canepa, General Manager, Shanghai Bracco Sine Pharmaceuticals Corp
- Veronica Acurio, Vice President, Greater China Area at 3M Health Care Business Group
11:40 am Closing words
11:45 am Webinar ends